Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HITNASDAQ:ICCHNYSE:NEUENASDAQ:RDZN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHITHealth In Tech$0.69+4.8%$4.59$0.59▼$7.59$37.89MN/A2.03 million shs1.30 million shsICCHICC$23.49$23.22$15.25▼$23.96$73.74M0.39,642 shsN/ANEUENeueHealth$6.60-2.4%$6.92$3.79▼$7.66$56.01M0.5619,981 shs20,751 shsRDZNRoadzen$1.18+13.5%$1.22$0.71▼$6.67$87.55M0.24716,994 shs89,494 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHITHealth In Tech+4.84%-9.91%-90.16%+69,369,900.00%+69,369,900.00%ICCHICC0.00%0.00%+2.58%+0.90%+46.81%NEUENeueHealth-2.37%+4.76%-9.96%-11.05%+4.75%RDZNRoadzen+13.46%+10.28%-3.67%-45.87%-81.85%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHITHealth In TechN/AN/AN/AN/AN/AN/AN/AN/AICCHICC1.6018 of 5 stars0.03.00.00.02.72.51.3NEUENeueHealth1.1437 of 5 stars1.03.00.00.01.94.20.6RDZNRoadzen2.2178 of 5 stars3.52.00.00.03.51.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHITHealth In Tech 0.00N/AN/AN/AICCHICC 0.00N/AN/AN/ANEUENeueHealth 2.00Hold$7.006.06% UpsideRDZNRoadzen 3.00Buy$5.00323.73% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHITHealth In Tech$19.49M1.94N/AN/AN/A∞ICCHICC$93.57M0.79$1.75 per share13.39$21.35 per share1.10NEUENeueHealth$936.66M0.06$55.00 per share0.12($158.35) per share-0.04RDZNRoadzen$42.89M2.04N/AN/A($0.41) per share-2.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHITHealth In TechN/AN/A0.00∞N/AN/AN/AN/AN/AICCHICC$4.26M$1.7310.58∞N/A7.13%9.58%3.01%5/5/2025 (Estimated)NEUENeueHealth-$1.15B-$22.63N/AN/AN/A-36.28%-6.40%8.45%5/6/2025 (Estimated)RDZNRoadzen-$99.67M-$1.51N/A∞N/A-248.79%N/A-269.99%N/ALatest HIT, ICCH, RDZN, and NEUE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/20/2025Q4 2024NEUENeueHealth-$2.29-$7.41-$5.12-$1.94$261.80 million$232.64 million2/24/2025Q4 2024ICCHICCN/A$0.54N/A$0.54N/A$23.94 million2/12/2025Q3 2025RDZNRoadzenN/A-$0.04N/A-$0.04N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHITHealth In TechN/AN/AN/AN/AN/AICCHICCN/AN/AN/AN/AN/ANEUENeueHealthN/AN/AN/AN/AN/ARDZNRoadzenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHITHealth In TechN/AN/AN/AICCHICC0.211.041.04NEUENeueHealthN/A0.680.68RDZNRoadzenN/A0.420.42Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHITHealth In TechN/AICCHICC46.50%NEUENeueHealth63.88%RDZNRoadzen24.73%Insider OwnershipCompanyInsider OwnershipHITHealth In TechN/AICCHICC25.80%NEUENeueHealth64.30%RDZNRoadzenN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHITHealth In Tech7954.62 millionN/AN/AICCHICC903.14 million2.38 millionNot OptionableNEUENeueHealth1,2528.29 million2.96 millionN/ARDZNRoadzen32474.19 millionN/ANot OptionableHIT, ICCH, RDZN, and NEUE HeadlinesRecent News About These CompaniesRoadzen Set to Benefit from India's New Road Safety RegulationsApril 1 at 8:54 AM | globenewswire.comRoadzen (NASDAQ:RDZN) Shares Down 5.3% - Time to Sell?March 26, 2025 | marketbeat.comRoadzen selected by general insurance company to manage Roadside AssistanceMarch 20, 2025 | markets.businessinsider.comRoadzen Selected by India’s Largest General Insurance Company to Manage its Roadside Assistance Program for a Second Consecutive Multi-Year TermMarch 19, 2025 | markets.businessinsider.comRoadzen Selected by India's Largest General Insurance Company to Manage its Roadside Assistance Program for a Second Consecutive Multi-Year TermMarch 19, 2025 | globenewswire.comRoadzen’s DrivebuddyAI Awarded Patent for AI-Driven Driver Risk Assessment, Transforming Global Road SafetyMarch 11, 2025 | markets.businessinsider.comRoadzen’s Drivebuddy AI awarded patent for AI-driven driver risk assessmentMarch 11, 2025 | markets.businessinsider.comRoadzen's DrivebuddyAI Awarded Patent for AI-Driven Driver Risk Assessment, Transforming Global Road SafetyMarch 11, 2025 | globenewswire.comNew to The Street’s Client Roadzen (NASDAQ: RDZN) Named to the Fintech40 Index of Global Fintech Leaders by L’Observatoire de la FintechMarch 8, 2025 | sacbee.comNew to The Street's Client Roadzen (NASDAQ: RDZN) Named to the Fintech40 Index of Global Fintech Leaders by L'Observatoire de la FintechMarch 7, 2025 | markets.businessinsider.comRoadzen’s MixtapeAI Wins ‘Best AI in Deep Tech’ at the Entrepreneur AI Awards 2025March 6, 2025 | finance.yahoo.comRoadzen's MixtapeAI Wins ‘Best AI in Deep Tech' at the Entrepreneur AI Awards 2025March 6, 2025 | globenewswire.comNew to The Street's Client Roadzen ($RDZN) 30-Second Commercial to Air Nationwide on CNBC, Fox Business, and Bloomberg Starting This WeekMarch 4, 2025 | markets.businessinsider.comNew to the Street's Client Roadzen NASDAQ (RDZN) 30-Second Commercial to Air Nationwide on CNBC, Fox Business, and Bloomberg Starting This WeekMarch 4, 2025 | markets.businessinsider.comMaxim Group Remains a Buy on Roadzen Inc (RDZN)February 18, 2025 | markets.businessinsider.comRoadzen Inc. Reports Q3 2025 Financial PerformanceFebruary 14, 2025 | tipranks.comRoadzen Inc.: Roadzen Reports Fiscal Third Quarter and First Nine-Months FY2025 Financial ResultsFebruary 13, 2025 | finanznachrichten.deRoadzen Reports Fiscal Third Quarter and First Nine-Months FY2025 Financial ResultsFebruary 12, 2025 | globenewswire.comIndividual investors among Roadzen, Inc.'s (NASDAQ:RDZN) largest stockholders and were hit after last week's 10% price dropFebruary 6, 2025 | finance.yahoo.comRoadzen Inc.: Roadzen Strengthens Balance Sheet, Eliminates $5.5 Million in Short-Term Liabilities By Paying $1.65 million in CashFebruary 4, 2025 | finanznachrichten.deRoadzen Inc. cuts liabilities and extends debt facilityFebruary 4, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesOccidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?By Thomas Hughes | March 6, 2025View Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?NVIDIA Stock Remains Stunningly Undervalued—Here’s WhyBy Thomas Hughes | March 11, 2025View NVIDIA Stock Remains Stunningly Undervalued—Here’s WhyS&P 500 & Nasdaq Hit Critical Support—Will Stocks Hold or Fall?By Jea Yu | March 10, 2025View S&P 500 & Nasdaq Hit Critical Support—Will Stocks Hold or Fall?3M to Hit $175 by Mid-Year, and Higher Highs Are LikelyBy Thomas Hughes | March 3, 2025View 3M to Hit $175 by Mid-Year, and Higher Highs Are LikelyThese 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?By Sarah Horvath | March 8, 2025View These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?HIT, ICCH, RDZN, and NEUE Company DescriptionsHealth In Tech NASDAQ:HIT$0.69 +0.03 (+4.84%) As of 04/1/2025 04:00 PM EasternHealth in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.ICC NASDAQ:ICCH$23.49 0.00 (0.00%) As of 03/13/2025ICC Holdings, Inc., together with its subsidiaries, provides property and casualty insurance products to the food and beverage industry in the United States. It offers commercial multi-peril, liquor liability, workers' compensation, and umbrella liability insurance products. The company markets its products through independent agents in Arizona, Colorado, Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Utah, and Wisconsin. ICC Holdings, Inc. was founded in 1950 and is headquartered in Rock Island, Illinois.NeueHealth NYSE:NEUE$6.62 -0.14 (-2.00%) As of 04/1/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.Roadzen NASDAQ:RDZN$1.18 +0.14 (+13.46%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$1.18 0.00 (0.00%) As of 04/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Roadzen, Inc., an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities. The company also provides insurance distribution platform that enables product creation and underwriting, re-insurer backing, and API exchange; and distribution, pre-inspection assistance, telematics, and roadside assistance. In addition, it offers insurance broker services. Roadzen, Inc. was founded in 2015 and is based in Burlingame, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy Amazon Falls Back to a Key Support Line: Here's How to Play It Berkshire Hathaway Gains Defy Stock Market Slump Tech Sell-Off Makes Microsoft Stock Look Like a Steal Palantir Stock Builds Momentum on New Partnership Amprius Market Gets Amped Up on Growth Outlook 3 Buyable Stocks With Solid Bottoms Ready to Rebound Game-Changing News for Advanced Micro Devices Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
